08.10.2015 • NewsDede WillamsBPShutdown & Turnaround

BP to Permanently Close Texas PX unit

BP has announced it will shutter its paraxylene (PX) plant at Texas City in the US with a capacity believed to exceed 1million t/y. The UK-based company cites market conditions as a reason for closing the plant.

BP will continue to operate its two other PX units in the US.

Without providing details the company said that following the closure of the PX facility it plans to reorganize its Texas City Chemicals plant to “better align and scale resources to meet our commitments and support our business goals, while maintaining safe, compliant and reliable operations.”

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.